journal article·2010-11

Fabrication of Novel Membranes for Biomedical Applications via Halidation of Poly(Methacrylic Acid‐co‐Methyl Methacrylate) and Crosslinking of Complementary Groups by PEG

Ali Negahi Shirazi, Diba Ghasemi, Mohammad Bagher Teimouri, Mohammad Imani

Advanced Engineering Materials· Volume 12· Issue 11
Publisher page

Abstract

Abstract Fabrication of novel, biocompatible and stimuli‐responsive membranes based on the crosslinking of poly(methacrylic acid‐co‐methyl methacrylate) using polyethylene glycol as a crosslinking agent is accomplished in a two‐stage procedure. Membranes are fabricated by casting and curing of the reactive precursors in different reaction compositions and durations according to a three‐level factorial design‐of‐experiments. The resulting membranes were thoroughly characterized using SEM, FTIR spectroscopy, thermal analysis and swelling experiments. The thermal properties were improved and swelling behavior of the hydrogels assures its stimuli‐responsive nature. MTT‐assay and cytotoxicity evaluations of the fabricated membranes elucidate acceptable biocompatibility profiles.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Sensor and Energy Harvesting Materials · Hydrogels: synthesis, properties, applications · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (28)

Show source-provided references
1. 10.1016/j.polymer.2006.01.08410.1016/j.polymer.2006.01.084 ↗
2. 10.1016/j.polymer.2008.12.01910.1016/j.polymer.2008.12.019 ↗
3. 10.1002/047002039310.1002/0470020393 ↗
4. 10.1002/pola.2026210.1002/pola.20262 ↗
5. 10.1002/jbm.a.3100310.1002/jbm.a.31003 ↗
6. 10.1016/j.ijpharm.2006.07.00910.1016/j.ijpharm.2006.07.009 ↗
7. 10.1016/S0014-3057(02)00385-310.1016/S0014-3057(02)00385-3 ↗
8. 10.1023/A:101366742606610.1023/A:1013667426066 ↗
9. 10.1021/bm034228110.1021/bm0342281 ↗
10. 10.1016/S0168-3659(00)00241-810.1016/S0168-3659(00)00241-8 ↗
11. 10.1016/S0168-3659(00)00303-510.1016/S0168-3659(00)00303-5 ↗
12. 10.1016/j.polymer.2006.10.02410.1016/j.polymer.2006.10.024 ↗
13. 10.1016/j.eurpolymj.2006.12.01310.1016/j.eurpolymj.2006.12.013 ↗
14. Negahi Shirazi A. · Int. J. Biomat.
15. Hashemi Doulabi A. S. · Iran Polym. J. · 2008 · 17 · 1
16. 10.1002/pola.1986.08024010810.1002/pola.1986.080240108 ↗
17. 10.1002/pola.1986.08024072610.1002/pola.1986.080240726 ↗
18. 10.1002/1521-3927(20000801)21:13<891::AID-MARC891>3.0.CO;2-D10.1002/1521-3927(20000801)21:13<891::AID-MARC891>3.0.CO;2-D ↗
19. 10.1002/1099-0518(20010101)39:1<196::AID-POLA220>3.0.CO;2-E10.1002/1099-0518(20010101)39:1<196::AID-POLA220>3.0.CO;2-E ↗
20. 10.1002/pol.1984.17022117410.1002/pol.1984.170221174 ↗
21. 10.1002/pol.1985.17023010810.1002/pol.1985.170230108 ↗
22. 10.1002/pol.1984.17022071210.1002/pol.1984.170220712 ↗
23. 10.1002/pola.1098310.1002/pola.10983 ↗
24. 10.1016/S0040-4039(02)00508-710.1016/S0040-4039(02)00508-7 ↗
25. 10.1002/pat.111210.1002/pat.1112 ↗
26. The United State Pharmacopeia XXV The National Formulary XX Rockville Md United States Pharmacopeial Convention Inc. 2002 pp.2579–2580.
27. The United State Pharmacopeia XXV The National Formulary XX Rockville Md United States Pharmacopeial Convention Inc. 2002 pp.2231–2232.
28. 10.1007/978-0-387-69002-5_1210.1007/978-0-387-69002-5_12 ↗